AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 86 filers reported holding AVROBIO INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,409,536 | +110.5% | 3,512,686 | +29.9% | 0.76% | +101.9% |
Q2 2023 | $2,570,021 | +6732.8% | 2,705,000 | +7091.7% | 0.38% | +6200.0% |
Q1 2023 | $37,613 | -99.6% | 37,613 | -94.6% | 0.01% | -99.6% |
Q3 2020 | $9,114,000 | -34.7% | 700,000 | -12.5% | 1.65% | +21.5% |
Q2 2020 | $13,960,000 | -10.3% | 800,000 | -20.0% | 1.36% | -37.9% |
Q1 2020 | $15,560,000 | -22.7% | 1,000,000 | 0.0% | 2.18% | -9.1% |
Q4 2019 | $20,130,000 | +71.9% | 1,000,000 | +20.6% | 2.40% | +20.1% |
Q3 2019 | $11,707,000 | – | 829,121 | – | 2.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |